Pistoia Alliance has expanded its Blockchain project to include data sharing, data identity, and data integrity

The Pistoia Alliance has expanded its blockchain project to include data sharing, data identity, and data integrity, according to a press release published on Feb 8.

The Pistoia Alliance is a not-for-profit organization established in 2007, with representatives from well-known pharmaceutical industry companies which include Pfizer, Novartiz, and GSK. The Pistoia Alliance was formed to help integrate new technology to assist in the companies’ respective research and development (R&D) fields.

The newest project will focus on the use of blockchain to validate sources in identifying data, to ensure data integrity, and to improve sharing between the organizations.

Prior to its foray into blockchain-based data management, Pistoia concentrated on educating the medical industry on the emerging technology. According to Pistoia, a recent survey found that access to skilled personnel and understanding of the technology are the primary barriers to blockchain’s adoption. That same survey reportedly stated that one-fifth of respondents do not think blockchain adds value beyond a standard database.

“Much of the industry is still at the ‘discussion’ stage of blockchain, we want to move beyond this and take action that actively supports members and leads to tangible outcomes that will benefit R&D, accelerate innovation and support the discovery of new treatments,” according to the president of the Pistoia Alliance, Steve Arlington.

Also read: Ontario Securities Commission has initiated a probe into Canada’s major crypto exchange QuadrigaCX

Source: https://cointelegraph.com/news/medical-rd-alliance-expands-blockchain-project-to-include-data-sharing